FDA refusing to review Moderna mRNA flu shot application

Moderna said connected Tuesday that the Food and Drug Administration (FDA) has refused to reappraisal its exertion for an mRNA flu vaccine, with the institution claiming this determination is inconsistent with erstwhile communications from the agency. In a property merchandise Tuesday, Moderna said the FDA’s Center for Biologics Evaluation and Research (CBER) told the company…